Andrew Fein
Stock Analyst at H.C. Wainwright
Total Price Targets
44
Stocks Covered
19
Sectors
Healthcare
Most Recent
Apr 14, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Andrew Fein
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| WVE | Wave Life Sciences Ltd. | $18.00 | $7.32 | +146.1% | 2 | Apr 14, 2026 |
| UTHR | United Therapeutics Corporation | $600.00 | $571.24 | +5.0% | 5 | Feb 26, 2026 |
| VRTX | Vertex Pharmaceuticals Incorporated | $591.00 | $425.06 | +39.0% | 4 | Feb 17, 2026 |
| AMLX | Amylyx Pharmaceuticals, Inc. | $28.00 | $16.04 | +74.6% | 2 | Feb 10, 2026 |
| BIIB | Biogen Inc. | $228.00 | $186.69 | +22.1% | 3 | Feb 9, 2026 |
| KALV | KalVista Pharmaceuticals, Inc. | $37.00 | $26.66 | +38.8% | 2 | Jan 9, 2026 |
| DBVT | DBV Technologies S.A. | $40.00 | $20.11 | +98.9% | 3 | Dec 18, 2025 |
| STOK | Stoke Therapeutics, Inc. | $50.00 | $33.22 | +50.5% | 1 | Dec 16, 2025 |
| PVLA | Palvella Therapeutics, Inc. | $190.00 | $125.87 | +50.9% | 1 | Dec 11, 2025 |
| KYMR | Kymera Therapeutics, Inc. | $134.00 | $81.54 | +64.3% | 3 | Dec 9, 2025 |
| DYN | Dyne Therapeutics, Inc. | $60.00 | $17.50 | +242.9% | 2 | Dec 8, 2025 |
| FULC | Fulcrum Therapeutics, Inc. | $18.00 | $7.37 | +144.4% | 2 | Nov 24, 2025 |
| PEPG | PepGen Inc. | $18.00 | $1.74 | +937.5% | 1 | Oct 28, 2025 |
| SVRA | Savara Inc. | $5.00 | $5.13 | -2.6% | 2 | Aug 15, 2025 |
| ARVN | Arvinas, Inc. | $24.00 | $10.55 | +127.4% | 2 | Jun 2, 2025 |
| ACAD | ACADIA Pharmaceuticals Inc. | $32.00 | $21.95 | +45.8% | 3 | May 19, 2025 |
| NBIX | Neurocrine Biosciences, Inc. | $168.00 | $131.64 | +27.6% | 4 | Apr 22, 2025 |
| CPRX | Catalyst Pharmaceuticals, Inc. | $35.00 | $28.77 | +21.7% | 1 | Jan 10, 2025 |
| INSM | Insmed Incorporated | $70.00 | $133.75 | -47.7% | 1 | May 29, 2024 |
Recent Activity
- Apr 14, 2026— Set$18.00price target onWVE(Wave Life Sciences Ltd.)
- Feb 26, 2026— Set$600.00price target onUTHR(United Therapeutics Corporation)
- Feb 17, 2026— Set$591.00price target onVRTX(Vertex Pharmaceuticals Incorporated)
- Feb 13, 2026— Set$518.00price target onVRTX(Vertex Pharmaceuticals Incorporated)
- Feb 10, 2026— Set$28.00price target onAMLX(Amylyx Pharmaceuticals, Inc.)
- Feb 9, 2026— Set$228.00price target onBIIB(Biogen Inc.)
- Jan 9, 2026— Set$37.00price target onKALV(KalVista Pharmaceuticals, Inc.)
- Dec 19, 2025— Set$30.00price target onWVE(Wave Life Sciences Ltd.)
- Dec 18, 2025— Set$40.00price target onDBVT(DBV Technologies S.A.)
- Dec 16, 2025— Set$50.00price target onSTOK(Stoke Therapeutics, Inc.)
- Dec 15, 2025— Set$35.00price target onDBVT(DBV Technologies S.A.)
- Dec 11, 2025— Set$190.00price target onPVLA(Palvella Therapeutics, Inc.)
- Dec 9, 2025— Set$134.00price target onKYMR(Kymera Therapeutics, Inc.)
- Dec 8, 2025— Set$60.00price target onDYN(Dyne Therapeutics, Inc.)
- Nov 24, 2025— Set$18.00price target onFULC(Fulcrum Therapeutics, Inc.)
- Oct 30, 2025— Set$525.00price target onUTHR(United Therapeutics Corporation)
- Oct 28, 2025— Set$18.00price target onPEPG(PepGen Inc.)
- Sep 5, 2025— Set$500.00price target onUTHR(United Therapeutics Corporation)
- Aug 15, 2025— Set$5.00price target onSVRA(Savara Inc.)
- Jul 31, 2025— Set$400.00price target onUTHR(United Therapeutics Corporation)
Frequently Asked Questions
Who is Andrew Fein?
Andrew Fein is a stock analyst at H.C. Wainwright covering 19 stocks primarily in Healthcare. They have issued 44 price targets since Feb 14, 2022.
What stocks does Andrew Fein cover?
Andrew Fein currently covers 19 stocks, including UTHR, VRTX, NBIX, BIIB, DBVT.
What is Andrew Fein's latest price target?
Andrew Fein's most recent price target was $18.00 on WVE (Wave Life Sciences Ltd.), set on Apr 14, 2026.
What is Andrew Fein's highest price target?
Andrew Fein's highest issued price target is $600.00 on UTHR, set on Feb 26, 2026.
More Analysts at H.C. Wainwright
Coverage based on publicly published price targets. Not investment advice.